Time-dependent effects of the neuropeptide PACAP on catecholamine secretion: Stimulation and desensitization

Hypertension

Volumn 34, Issue 5, 1999, Pages 1152-1162

  Taupenot, Laurent ^a,b   Mahata, Manjula ^a   Mahata, Sushil K ^a   O'Connor, Daniel T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Catecholamines; Chromaffin; Chromogranin; Desensitization; PC12; Peptides

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CADMIUM; CALCIUM CHANNEL BLOCKING AGENT; CHROMOGRANIN A; DIHYDROPYRIDINE DERIVATIVE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NICKEL; PHOSPHOLIPASE C INHIBITOR; THAPSIGARGIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; DOSE TIME EFFECT RELATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION;

EID: 0032750033     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.5.1152     Document Type: Article

References (49)

1. Miyata A, Jiang L, Stibbs HH, Arimura A. Chemical characterization of vasoactive intestinal polypeptide-like immunoreactivity in ovine hypothalamus and intestine. Regul Pept. 1992;38:145-154.
2. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul Pept. 1992;37:287-303.
3. Arimura A, Shioda S. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol. 1995;16:53-88.
4. Rawlings SR, Hezareh M. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocr Rev. 1996; 17:4-29.
5. Tabarin A, Chen D, Hakanson R, Sundler F. Pituitary adenylate cyclase-activating peptide in the adrenal gland of mammals: distribution, characterization and responses to drugs. Neuroendocrinology. 1994;59: 113-119.
6. Moller K, Sundler F. Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla. Regul Pept. 1996;63:129-139.
7. + influx-dependent membrane depolarization in bovine adrenal chromaffin cells. Endocrinology. 1996;137:956-966.
8. Isobe K, Nakai T, Takuwa Y, Ca(2+)-dependent stimulatory effect of pituitary adenylate cyclase-activating polypeptide on catecholamine secretion from cultured porcine adrenal medullary chromaffin cells. Endocrinology. 1993;132:1757-1765.
9. Przywara DA, Guo X, Angelilli ML, Wakade TD, Wakade AR. A non-cholinergic transmitter, pituitary adenylate cyclase-activating polypeptide, utilizes a novel mechanism to evoke catecholamine secretion in rat adrenal chromaffin cells. J Biol Chem. 1996;271:10545-10550.
10. Marley PD, Cheung CY, Thomson KA, Murphy R. Activation of tyrosine hydroxylase by pituitary adenylate cyclase-activating polypeptide (PACAP-27) in bovine adrenal chromaffin cells. J Auton Nerv Syst. 1996;60:141-146.
11. Taupenot L, Mahata SK, Wu H, O'Connor DT. Peptidergic stimulation of secretion and transcription in chromaffin cells: cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). J Clin Invest. 1998;101:863-876.
12. Babinski K, Bodart V, Roy M, De Lean A, Ong H. Pituitary adenylate-cyclase activating polypeptide (PACAP) evokes long-lasting secretion and de novo biosynthesis of bovine adrenal medullary neuropeptides. Neuropeptides. 1996;30:572-582.
13. Boksa P, Livett BG. Desensitization to nicotinic cholinergic agonists and K+, agents that stimulate catecholamine secretion, in isolated adrenal chromaffin cells. J Neurochem. 1984;42:607-617.
14. Pisegna JR, Wank SA. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad Sci U S A. 1993;90:6345-6349.
15. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 1993;365:170-175.
16. Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, Journot L. Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem. 1996;271:22146-22151.
17. Hezareh M, Schlegel W, Rawlings SR. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta. J Neuroendocrinol. 1996;8:367-374.
18. Freedman NJ, Lefkowitz RJ. Desensitization of G protein-coupled receptors. Recent Prog Horm Res. 1996;51:319-351; discussion 352-353.
19. Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Vesicular monoamine transport inhibitors: novel action at calcium channels to prevent catecholamine secretion. Hypertension. 1996;28:414-420.
20. Wu H, Rozansky DJ, Webster NJ, O'Connor DT. Cell type-specific gene expression in the neuroendocrine system: a neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein. J Clin Invest. 1994;94:118-129.
21. Tang K, Wu H, Mahata SK, Taupenot L, Rozansky DJ, Parmer RJ, O'Connor DT. Stimulus-transcription coupling in pheochromocytoma cells: promoter region-specific activation of chromogranin a biosynthesis. J Biol Chem. 1996;271:28382-28390.
22. Robberecht P, Woussen-Colle MC, De Neef P, Gourlet P, Buscail L, Vandermeers A, Vandermeers-Piret MC, Christophe J. The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP [1-27] and PACAP [1-38]) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes. Febs Letters. 1991;286:133-136.
23. McArdle CA, Poch A, Schomerus E, Kratzmeier M. Pituitary adenylate cyclase-activating polypeptide effects in pituitary cells: modulation by gonadotropin-releasing hormone in alpha T3-1 cells. Endocrinology. 1994;134:2599-2605.
24. Deutsch PJ, Sun Y. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem. 1992;267: 5108-5113.
25. Gudermann T, Schoneberg T, Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu Rev Neurosci. 1997;20:399-427.
26. Zhang JF, Randall AD, Ellinor PT, Horne WA, Sather WA, Tanabe T, Schwarz TL, Tsien RW. Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology. 1993;32:1075-1088.
27. Liu H, Felix R, Gurnett CA, De Waard M, Witcher DR, Campbell KP. Expression and subunit interaction of voltage-dependent Ca2+ channels in PC12 cells. J Neurosci. 1996;16:7557-7565.
28. Usowicz MM, Porzig H, Becker C, Reuter H. Differential expression by nerve growth factor of two types of Ca2+ channels in rat phaeochromocytoma cell lines. J Physiol (Lond). 1990;426:95-116.
29. Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988;11:431-438.
30. Nooney JM, Lambert RC, Feltz A. Identifying neuronal non-L Ca2+ channels-more than stamp collecting? Trends Pharmacol Sci. 1997;18: 363-371.
31. Berridge MJ. Capacitative calcium entry [see comments]. Biochem J. 1995;312:1-11.
32. Favre CJ, Nüsse O, Lew DP, Krause KH. Store-operated Ca2+ influx: what is the message from the stores to the membrane? J Lab Clin Med. 1996;128:19-26.
33. Bennett DL, Bootman MD, Berridge MJ, Cheek TR. Ca2+ entry into PC12 cells initiated by ryanodine receptors or inositol 1,4,5-trisphosphate receptors. Biochem J. 1998;329:349-357.
34. Koizumi S, Inoue K. Functional coupling of secretion and capacitative calcium entry in PC12 cells [corrected and republished article originally printed in Biochem Biophys Res Commun. 1998;244:293-297]. Biochem Biophys Res Commun. 1998;247:293-298.
35. Powis DA, Clark CL, O'Brien KJ. Depleted internal store-activated Ca2+ entry can trigger neurotransmitter release in bovine chromaffin cells [published erratum appears in Neurosci Lett. 1996;210:74]. Neurosci Lett. 1996;204:165-168.
36. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, JaxaChamiec A, Leigh BK, McCarthy SA, Moores KE, Rink TJ. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J. 1990;271:515-522.
37. Ehrlich BE. Functional properties of intracellular calcium-release channels. Curr Opin Neurobiol. 1995;5:304-309.
38. Tanaka K, Shibuya I, Uezono Y, Ueta Y, Toyohira Y, Yanagihara N, Izumi F, Kanno T, Yamashita H. Pituitary adenylate cyclase-activating polypeptide causes Ca2+ release from ryanodine/caffeine stores through a novel pathway independent of both inositol trisphosphates and cyclic AMP in bovine adrenal medullary cells. J Neurochem. 1998;70: 1652-1661.
39. Tang K, Wu H, Gill Biol, Mahata SK, Mahata M, O'Connor DT. Stimulus coupling to transcription versus secretion in pheochromocytoma cells: convergent and divergent signal transduction pathways, and the crucial role for route of cytosolic calcium entry and protein kinase C. J Clin Invest. 1997;100:1180-1192.
40. Mahata SK, Mahata M, Wu H, Parmer RJ, Oconnor DT. Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin A biosynthesis. Neuroscience. 1999;88:405-424.
41. Muller A, Lutz-Bucher B, Kienlen-Campard P, Koch B, Loeffler JP. Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases. J Neurochem. 1998;70:1431-1440.
42. Widnell KL, Chen JS, Iredale PA, Walker WH, Duman RS, Habener JF, Nestler EJ. Transcriptional regulation of CREB (cyclic AMP response element-binding protein) expression in CATH.a cells. J Neurochem. 1996;66:1770-1773.
43. Perrin D, Germeshausen A, Soling HD, Wuttke W, Jarry H. Enhanced cAMP production mediates the stimulatory action of pituitary adenylate cyclase activating polypeptide (PACAP) on in vitro catecholamine secretion from bovine adrenal chromaffin cells. Exp Clin Endocrinol Diabetes. 1995;103:81-87.
44. Bader MF, Sontag JM, Thierse D, Aunis D. A reassessment of guanine nucleotide effects on catecholamine secretion from permeabilized adrenal chromaffin cells. J Biol Chem. 1989;264:16426-16434.
45. Gillis KD, Mossner R, Neher E. Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron. 1996;16:1209-1220.
46. Adelman JP. Proteins that interact with the pore-forming subunits of voltage-gated ion channels. Curr Opin Neurobiol. 1995;5:286-295.
47. Wickman KD, Clapham DE. G-protein regulation of ion channels. Curr Opin Neurobiol. 1995;5:278-285.
48. α11 subunits. EMBO J. 1996;15:5833-5838.
49. Montell C. New light on TRP and TRPL. Mole Pharmacol. 1997;52: 755-763.